Mushroom Compound Shows Promise Against Colorectal Cancer in New Study
Researchers find that combining Ganoderma lucidum and Sanghuangporus vaninii extracts may fight colorectal cancer through vitamin D and Wnt pathways.
Summary
Chinese researchers investigated a compound extract from two medicinal mushrooms - Ganoderma lucidum (reishi) spores and Sanghuangporus vaninii - for anti-cancer effects. Using network pharmacology and gene expression analysis, they found the ethanol extract significantly inhibited colorectal cancer cell growth both in lab dishes and animal models. The compound worked by targeting two key cellular pathways: the vitamin D receptor pathway (via CYP24A1) and Wnt signaling (via TERT). The mushroom extract suppressed cancer cell spread, stopped cell division, and triggered programmed cell death. Notably, the combined extract performed better than either mushroom alone, suggesting synergistic effects between the two fungi.
Detailed Summary
This study explores the anti-cancer potential of combining two traditional medicinal mushrooms that have been used in Asian medicine for centuries. The research matters because colorectal cancer remains a leading cause of cancer deaths worldwide, and natural compounds offer promising alternatives to conventional treatments.
Researchers from Xi'an Jiaotong University tested eight different mushroom extracts on cancer cells, finding that the ethanol extract from combined Ganoderma lucidum spores and Sanghuangporus vaninii (GSEE) showed the strongest anti-cancer effects. They further refined this to identify the ethyl acetate fraction (GSEAE) as the most active component.
Using advanced computational methods and gene expression analysis, the team discovered that GSEAE works through two major cellular pathways. First, it affects vitamin D signaling by modulating CYP24A1, an enzyme that breaks down active vitamin D. Second, it targets the Wnt pathway through TERT, a protein involved in cell immortalization. Both pathways are crucial in cancer development and progression.
In laboratory and animal studies, GSEAE demonstrated multiple anti-cancer effects: it prevented cancer cells from spreading, arrested their growth cycle, and induced mitochondrial-mediated cell death. Importantly, the combined extract outperformed either mushroom used alone, indicating synergistic interactions between their bioactive compounds.
While promising, this research is still in early stages and based only on laboratory and animal studies. Human clinical trials would be needed to confirm safety and effectiveness before any therapeutic applications.
Key Findings
- Combined mushroom extract outperformed individual extracts against colorectal cancer cells
- Treatment worked through vitamin D receptor and Wnt signaling pathways
- Extract prevented cancer spread and induced programmed cell death in lab studies
- Ethyl acetate fraction showed strongest anti-tumor activity
- Effects confirmed in both cell culture and animal models
Methodology
Researchers used MTT assays to test cell viability, Chou-Talalay method to assess synergistic effects, and network pharmacology combined with transcriptomics to identify mechanisms. Both in vitro cell culture and in vivo animal models were employed for validation.
Study Limitations
This summary is based on the abstract only, limiting detailed analysis. The study used only laboratory and animal models - human clinical trials are needed to establish safety and efficacy. The specific bioactive compounds responsible for the effects were not fully characterized.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.